1-2 of 2
Christopher Hatton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Free
Clinical Trials & Observations
Emma Morris, Kirsty Thomson, Charles Craddock, Prem Mahendra, Donald Milligan, Gordon Cook, Graeme Murray Smith, Anne Parker, Steve Schey, Rajesh Chopra, Christopher Hatton, Jane Tighe, Anne Hunter, Karl Peggs, David Linch, Anthony Goldstone, Stephen Mackinnon
Journal: Blood
Blood (2004) 104 (13): 3865–3871.
https://doi.org/10.1182/blood-2004-03-1105
Published: 2004
Journal Articles

Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma

Free
Brief Report
Karen Pulford, Brunangelo Falini, Alison H. Banham, Diana Codrington, Helen Roberton, Christopher Hatton, David Y. Mason
Journal: Blood
Blood (2000) 96 (4): 1605–1607.
https://doi.org/10.1182/blood.V96.4.1605
Published: 2000